Is ARK Next Generation Internet ETF a Good Investment?
The ARK Next Generation Internet ETF looks like a pretty…
Buy
54
TKR Quote, Financials, Valuation and Earnings
Last price:
$72.61
Seasonality move
:
5.59%
Day range:
$72.29 - $74.28
52-week range:
$69.35 - $94.71
Dividend yield:
1.83%
P/E ratio:
15.37x
P/S ratio:
1.14x
P/B ratio:
1.77x
Volume:
680.3K
Avg. volume:
498K
1-year change:
-6.3%
Market cap:
$5.2B
Revenue:
$4.8B
EPS (TTM):
$4.81
Analysts' Opinion
-
Consensus RatingThe Timken has received a consensus rating of Buy. The company's average rating is a Buy based on 6 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $89.64, The Timken has an estimated upside of 21.21% from its current price of $73.95.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $73.00 representing 100% downside risk from its current price of $73.95.
Fair Value
-
According to the consensus of 10 analysts, The Timken has 21.21% upside to fair value with a price target of $89.64 per share.
TKR vs. S&P 500
-
Over the past 5 trading days, The Timken has overperformed the S&P 500 by 4.04% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
The Timken does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
The Timken revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter The Timken reported revenues of $1.1B.
Earnings Growth
-
The Timken earnings have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter The Timken reported earnings per share of $1.16.
Enterprise value:
7.2B
EV / Invested capital:
--
Price / LTM sales:
1.14x
EV / EBIT:
12.09x
EV / Revenue:
1.56x
PEG ratio (5yr expected):
--
EV / Free cash flow:
27.99x
Price / Operating cash flow:
20.45x
Enterprise value / EBITDA:
8.84x
Gross Profit (TTM):
$1.4B
Return On Assets:
5.21%
Net Income Margin (TTM):
7.41%
Return On Equity:
12.09%
Return On Invested Capital:
6.67%
Operating Margin:
11.98%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $4.4B | $4.8B | $4.6B | $1.1B | $1.1B | |
| Gross Profit | $1.3B | $1.5B | $1.4B | $355.6M | $344.4M | |
| Operating Income | $609M | $707M | $616.8M | $158.5M | $135M | |
| EBITDA | $742.5M | $886.7M | $810.7M | $203.9M | $198.6M | |
| Diluted EPS | $4.98 | $5.95 | $4.81 | $1.23 | $1.16 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2B | $2.2B | $2.5B | $2.6B | $2.7B | |
| Total Assets | $4.9B | $5.1B | $5.3B | $6.2B | $6.8B | |
| Current Liabilities | $740.4M | $846M | $1.2B | $1.5B | $910.3M | |
| Total Liabilities | $2.8B | $2.8B | $3.1B | $3.6B | $3.7B | |
| Total Equity | $2.1B | $2.4B | $2.2B | $2.6B | $3.1B | |
| Total Debt | $1.6B | $1.5B | $1.8B | $2.2B | $2.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $325M | $658.4M | $425.4M | $194.3M | $123.2M | |
| Cash From Investing | -$299.9M | -$930.4M | -$457.4M | -$187.1M | -$190.6M | |
| Cash From Financing | $41.6M | $353.9M | $57.3M | $26.6M | -$2.2M | |
| Free Cash Flow | $157.8M | $467.6M | $256.1M | $150.7M | $88.2M | |
TKR
Sector
Market Cap
$5.2B
$746.2M
Price % of 52-Week High
78.09%
78.37%
Dividend Yield
1.83%
0%
Shareholder Yield
-1.73%
2.31%
1-Year Price Total Return
-6.3%
-1.82%
Beta (5-Year)
1.391
0.915
Dividend yield:
1.83%
Annualized payout:
$1.30
Payout ratio:
28.04%
Growth streak:
10 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$72.07
200-day SMA
Sell
Level
$82.20
Bollinger Bands (100)
Sell
Level
74.72 - 83.96
Chaikin Money Flow
Buy
Level
111.8M
20-day SMA
Buy
Level
$73.12
Relative Strength Index (RSI14)
Buy
Level
50.43
ADX Line
Buy
Level
28.89
Williams %R
Neutral
Level
-25.5457
50-day SMA
Sell
Level
$75.88
MACD (12, 26)
Sell
Level
-1.03
25-day Aroon Oscillator
Sell
Level
-68
On Balance Volume
Neutral
Level
128.5M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.622)
Buy
CA Score
(Annual)
Level (-0.1787)
Buy
Beneish M-Score
(Annual)
Level (-2.621)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-0.2624)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
The Timken Company is a manufacturer of bearings, gear belts, industrial motion products and chain-related products. The company sells its portfolio of bearings, including tapered, spherical and cylindrical roller bearings, and thrust and ball bearings, through a network of authorized dealers to end users or directly to original equipment manufacturers. End-market sectors include general industrial, automotive, rail, energy, heavy truck, defense, agriculture, metals, mining, civil aerospace, construction, pulp and paper, and cement industries. Its segments are Engineered Bearings and Industrial Motion. Timken generates majority of its revenue in the United States of America.
Stock Forecast FAQ
In the current month, TKR has received 6 Buy ratings 4 Hold ratings, and 0 Sell ratings. The TKR average analyst price target in the past 3 months is $89.64.
-
Where Will The Timken Stock Be In 1 Year?
According to analysts, the consensus estimate is that The Timken share price will rise to $89.64 per share over the next 12 months.
-
What Do Analysts Say About The Timken?
Analysts are divided on their view about The Timken share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that The Timken is a Sell and believe this share price will drop from its current level to $73.00.
-
What Is The Timken's Price Target?
The price target for The Timken over the next 1-year time period is forecast to be $89.64 according to 10 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is TKR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for The Timken is a Buy. 6 of 10 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of TKR?
You can purchase shares of The Timken via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase The Timken shares.
-
What Is The The Timken Share Price Today?
The Timken was last trading at $72.61 per share. This represents the most recent stock quote for The Timken. Yesterday, The Timken closed at $73.95 per share.
-
How To Buy The Timken Stock Online?
In order to purchase The Timken stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Marvell Stock Up?
Semiconductor and data infrastructure company Marvell Technology (NASDAQ:MRVL) absolutely trounced…
Why Is General Electric Stock Going Up?
General Electric Company, doing business these days as GE Aerospace…
Stock Ideas
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Sell
44
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
1
IONQ alert for Jan 10
IonQ [IONQ] is up 7.07% over the past day.
Sell
47
CEG alert for Jan 10
Constellation Energy [CEG] is up 25.15% over the past day.
Sell
8
CRNX alert for Jan 10
Crinetics Pharmaceuticals [CRNX] is down 16.31% over the past day.
